Investing
Cathie Wood's ARK Invest Buys Over 240,000 Shares of Fate Therapeutics
Published:
A couple of the ARK Invest exchange-traded funds run by ETF star Cathie Wood made a sizable purchase on Tuesday. The fund bought over 240,000 shares of Fate Therapeutics Inc. (NASDAQ: FATE) altogether, as the price of these ETFs were somewhat mixed on the day. Note that these funds are up significantly in the past year.
Specifically, ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 55,163 shares of Fate Therapeutics, and ARK Innovation ETF (NYSEARCA: ARKK) bought 186,114 shares. At Tuesday’s closing price, this would have valued this purchase at roughly $20.1 million altogether. Even though this is a small fraction of the total holdings, every little bit counts. ARKG is up 50% in the past year and ARKK is up closer to 46%.
Here is a look at the other purchases across the ARK ETFs:
Fund | Ticker | Company | Shares |
---|---|---|---|
ARKF | ETSY | Etsy | 90,831 |
ARKF | HOOD | Robinhood Markets | 89,622 |
ARKG | SRNG | Soaring Eagle Acquisition | 214,751 |
ARKG | SMFR | Sema4 | 96,000 |
ARKG | SGFY | Signify Health | 31,587 |
ARKG | RPTX | Repare Therapeutics | 11,809 |
ARKG | MASS | 908 Devices | 46,488 |
ARKG | BEAM | Beam Therapeutics | 3,074 |
ARKG | EDIT | Editas Medicine | 35,000 |
ARKG | FATE | Fate Therapeutics | 55,163 |
ARKK | VCYT | Veracyte | 16,379 |
ARKK | PACB | Pacific Biosciences of California | 190,000 |
ARKK | FATE | Fate Therapeutics | 186,114 |
ARKK | BEAM | Beam Therapeutics | 37,694 |
ARKQ | MKFG | Markforged | 397,767 |
ARKQ | AVAV | Aerovironment | 22,232 |
ARKW | CND | Conchord Acquisition | 3,000 |
ARKW | KVSB | Khosla Ventures Acquisition II | 10,000 |
ARKW | VUZI | Vuzix | 90,000 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
Retirement can be daunting, but it doesn’t need to be.
Imagine having an expert in your corner to help you with your financial goals. Someone to help you determine if you’re ahead, behind, or right on track. With SmartAsset, that’s not just a dream—it’s reality. This free tool connects you with pre-screened financial advisors who work in your best interests. It’s quick, it’s easy, so take the leap today and start planning smarter!
Don’t waste another minute; get started right here and help your retirement dreams become a retirement reality.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.